India Ratings revises Wockhardt’s bank facilities ratings

29 Aug 2019

Credit rating agency, India Ratings and Research Private has revised Wockhardt’s ratings for short-term Bank facilities / Commercial Paper to ‘A4+’ from ‘A3’; and for long-term loan facilities rating to ‘BB+ / Negative’ from ‘BBB-/Negative’. The agency has revised the rating of the company owing to refinancing risks, R&D expenses, regulatory overhang etc.

Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.

Related Wockhardt Ltd. Links:

Wockhardt Share Price

271.30 0.00 (0.00%) Jul 07, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 479.45
Lupin 870.80
Dr. Reddys Lab 3822.85
Piramal Enterprises 1416.55
Cadila Healthcare 361.85
View more..
Sensex vs Wockhardt
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback